Vaccinex Yönetim

Yönetim kriter kontrolleri 3/4

Vaccinex's CEO is Maurice Zauderer, appointed in Apr 2001, has a tenure of 23.58 years. total yearly compensation is $430.28K, comprised of 95.7% salary and 4.3% bonuses, including company stock and options. directly owns 0.14% of the company’s shares, worth $10.64K. The average tenure of the management team and the board of directors is 15.8 years and 20.8 years respectively.

Anahtar bilgiler

Maurice Zauderer

İcra Kurulu Başkanı

US$430.3k

Toplam tazminat

CEO maaş yüzdesi95.7%
CEO görev süresi23.6yrs
CEO sahipliği0.1%
Yönetim ortalama görev süresi15.8yrs
Yönetim Kurulu ortalama görev süresi20.8yrs

Son yönetim güncellemeleri

Recent updates

Rock star Growth Puts Vaccinex (NASDAQ:VCNX) In A Position To Use Debt

Aug 17
Rock star Growth Puts Vaccinex (NASDAQ:VCNX) In A Position To Use Debt

CEO Tazminat Analizi

Maurice Zauderer'un ücretlendirmesi Vaccinex'un kazancına kıyasla nasıl değişti?
TarihToplam TazminatMaaşŞirket Kazançları
Jun 30 2024n/an/a

-US$18m

Mar 31 2024n/an/a

-US$19m

Dec 31 2023US$430kUS$412k

-US$20m

Sep 30 2023n/an/a

-US$22m

Jun 30 2023n/an/a

-US$22m

Mar 31 2023n/an/a

-US$20m

Dec 31 2022US$425kUS$401k

-US$20m

Sep 30 2022n/an/a

-US$19m

Jun 30 2022n/an/a

-US$20m

Mar 31 2022n/an/a

-US$20m

Dec 31 2021US$402kUS$375k

-US$22m

Sep 30 2021n/an/a

-US$24m

Jun 30 2021n/an/a

-US$28m

Mar 31 2021n/an/a

-US$28m

Dec 31 2020US$444kUS$357k

-US$29m

Sep 30 2020n/an/a

-US$29m

Jun 30 2020n/an/a

-US$28m

Mar 31 2020n/an/a

-US$30m

Dec 31 2019US$399kUS$347k

-US$32m

Sep 30 2019n/an/a

-US$34m

Jun 30 2019n/an/a

-US$33m

Mar 31 2019n/an/a

-US$31m

Dec 31 2018US$337kUS$337k

-US$30m

Sep 30 2018n/an/a

-US$24m

Jun 30 2018n/an/a

-US$24m

Mar 31 2018n/an/a

-US$23m

Dec 31 2017US$408kUS$328k

-US$22m

Tazminat ve Piyasa: Maurice's total compensation ($USD430.28K) is below average for companies of similar size in the US market ($USD655.65K).

Tazminat ve Kazançlar: Maurice's compensation has increased whilst the company is unprofitable.


CEO

Maurice Zauderer (78 yo)

23.6yrs

Görev süresi

US$430,277

Tazminat

Dr. Maurice Zauderer, Ph.D. Co-Founded Vaccinex, Inc. in April 2001 and also serves as its President and Chief Executive Officer since April 2001. Dr. Zauderer serves as Director of Vaccinex Inc. since Apr...


Liderlik Ekibi

İsimPozisyonGörev süresiTazminatSahiplik
Maurice Zauderer
Co-Founder23.6yrsUS$430.28k0.14%
$ 10.6k
Elizabeth Evans
COO and Senior VP of Discovery & Translational Medicine3.5yrsUS$303.21k0.0018%
$ 135.7
Ernest Smith
Senior VP of Research & Chief Scientific Officer15.9yrsUS$308.90k0.0015%
$ 115.0
Jill Sanchez
Chief Financial Officerless than a yearVeri yokVeri yok
John Leonard
Senior Vice President of Development15.8yrsVeri yok0.00062%
$ 47.5

15.8yrs

Ortalama Görev Süresi

52yo

Ortalama Yaş

Deneyimli Yönetim: VCNX's management team is seasoned and experienced (15.8 years average tenure).


Yönetim Kurulu Üyeleri

İsimPozisyonGörev süresiTazminatSahiplik
Maurice Zauderer
Co-Founder23.6yrsUS$430.28k0.14%
$ 10.6k
Bala Manian
Independent Director19.9yrsUS$82.50k0%
$ 0
Gerald Van Strydonck
Independent Director21.7yrsUS$90.00k0.021%
$ 1.6k
Anthony Tolcher
Scientific and Clinical Advisorno dataVeri yokVeri yok
Max Vasquez
Member of Scientific & Clinical Advisory Boardno dataVeri yokVeri yok
Mark Tullman
Scientific and Clinical Advisorno dataVeri yokVeri yok
Khurram Bashir
Scientific and Clinical Advisorno dataVeri yokVeri yok
Albert Friedberg
Chairman of the Board23.6yrsVeri yok0.081%
$ 6.2k
Laura Balcer
Scientific & Clinical Advisorno dataVeri yokVeri yok
Peter Calabresi
Scientific & Clinical Advisorno dataVeri yokVeri yok
Barbara Yanni
Independent Director9.8yrsUS$85.00k0%
$ 0
Jacob Frieberg
Independent Lead Director9.8yrsUS$75.00k0.064%
$ 4.9k

20.8yrs

Ortalama Görev Süresi

77.5yo

Ortalama Yaş

Deneyimli Yönetim Kurulu: VCNX's board of directors are seasoned and experienced ( 20.8 years average tenure).